About this trial
Improving pain in the patients with adhesive capsulitis by comparing the effect of combined shoulder anterior capsular block and intraarticular steroid injection versus intraarticular steroid injection.
Eligibility criteria
Qualifiers
Patients acceptance
Age: 41-65 years old
Sex: both sex (males or females).
Physical status: American Society of Anesthesiologist (ASA) І, II.
Disqualifiers
Shoulder pain due to secondary causes, e.g. acute trauma, fractures, bony deformity, glenohumeral joint pathology, acromioclavicular joint pathology and rotator cuff disorder.
Patient with any contraindications of regional blocks (as coagulopathy or local infection at injection site)
Patients with known history of allergy to the study drugs (bupivacaine and methylprednisolone).
Advanced hepatic, renal, cardiovascular, neurologic and respiratory diseases, uncontrolled diabetes mellitus and thyroid.
Trial design
Treatments tested in this trial
- Group Group Shoulder anterior capsular block (SHAC)
- Group intraarticular steroid injection (IASI)